Skip to main content

Table 1 Patient characteristics

From: Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

Characteristic No. (%) (n = 60)
Gender  
 Male 38 (63.3)
 Female 22 (36.7)
Age group  
 < 6 years 26 (43.3)
 6-11 years 34 (56.7)
Donor  
 MUD 20 (33.3)
 MMFD 27 (45.0)
 MFD 13 (21.7)
Primary diagnosis  
 ALL 6 (10.0)
 ALL relapse 11 (18.3)
 AML 2 (3.3)
 AML relapse 2 (3.3)
 Biphenotypic leukemia 1 (1.7)
 CML 2 (3.3)
 JMML 3 (5.0)
 MDS 5 (8.3)
 Solid tumors 7 (11.7)
 Aplastic anemia 9 (15.0)
 Neurometabolic diseases 4 (6.7)
 Immunologic diseases 6 (10.0)
 Chediak-Higashi-syndrome 1 (1.7)
 Kostmann disease 1 (1.7)
Graft-versus-Host-Disease  
 Grade I 23 (38.3)
 Grade II 3 (5.0)
 Grade III 4 (6.7)
 Grade IV 2 (3.3)
 Chronic limited 2 (3.3)
 Chronic extensive 1 (1.7)
  1. Abbreviation: ALL, acute lymphoblastic leukemia; AML, acute myelogenous leukemia; CML, chronic myeloid leukemia; JMML, juvenile myelomonocytic leukemia; MDS, myelodysplastic syndromes, MFD, matched family donor; MMFD, mismatched family donor; MUD, matched unrelated donor.